key: cord-0697508-g94defp5
authors: Sahin, Erdem; Bozdayi, Gulendam; Yigit, Selin; Muftah, Hager; Dizbay, Murat; Tunccan, Ozlem G.; Fidan, Isil; Caglar, Kayhan
title: Genomic characterization of SARS‐CoV‐2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins
date: 2021-07-16
journal: J Med Virol
DOI: 10.1002/jmv.27188
sha: a07a35d548e992dd79bb831c1a266b3ed7d3d09f
doc_id: 697508
cord_uid: g94defp5

Novel mutations have been emerging in the genome of severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2); consequently, the evolving of more virulent and treatment resistance strains have the potential to increase transmissibility and mortality rates. The characterization of full‐length SARS‐CoV‐2 genomes is critical for understanding the origin and transmission pathways of the virus, as well as identifying mutations that affect the transmissibility and pathogenicity of the virus. We present an analysis of the mutation pattern and clade distribution of full‐length SARS‐CoV‐2 genome sequences obtained from specimens tested at Gazi University Medical Virology Laboratory. Viral RNA was extracted from nasopharyngeal specimens. Next‐generation sequencing libraries were prepared and sequenced on Illumina iSeq 100 platform. Raw sequencing data were processed to obtain full‐length genome sequences and variant calling was performed to analyze amino acid changes. Clade distribution was determined to understand the phylogenetic background in relation to global data. A total of 293 distinct mutations were identified, of which 152 missense, 124 synonymous, 12 noncoding, and 5 deletions. The most frequent mutations were P323L (nsp12), D614G (ORF2/S), and 2421C>T (5′‐untranslated region) found simultaneously in all sequences. Novel mutations were found in nsp12 (V111A, H133R, Y453C, M626K) and ORF2/S (R995G, V1068L). Nine different Pangolin lineages were detected. The most frequently assigned lineage was B.1.1 (17 sequences), followed by B.1 (7 sequences) and B.1.1.36 (3 sequences). Sequence information is essential for revealing genomic diversity. Mutations might have significant functional implications and analysis of these mutations provides valuable information for therapeutic and vaccine development studies. Our findings point to the introduction of the virus into Turkey through various sources and the subsequent spread of several key variants.

Coronaviruses are a large family of RNA viruses, which can cause mild to severe respiratory infections in humans. 1 The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is a newly discovered virus that causes the respiratory disease called the coronavirus disease 2019 and was first reported in Wuhan City, China, in mid-December 2019. 2 It was declared as a pandemic by the World Health Organization on March 11, 2020. The first case of SARS-CoV-2 infection in Turkey was identified on March 11, 2020 , in a person with recent travel history to Europe, and the first death was announced on March 17, 2020 . Since the first confirmed case, the number of cases has risen rapidly both globally and in Turkey, and it continues to rise. 3 According to data by the Turkish Ministry of Health, over 4 million cases have been reported in Turkey as of June 2021, including over 40 000 deaths. 4 Significant public health measures have been implemented all over the country to have control over the number of cases. Following the onset of the COVID-19 pandemic, virology laboratories were reorganized to ensure early diagnosis of the infection. In this context, various diagnostic techniques such as real-time polymerase chain reaction (PCR), rapid antibody and enzyme-linked immunosorbent assay tests have been used in the laboratories for the rapid and accurate diagnosis of COVID- 19. 5 SARS-CoV-2 is an RNA virus that frequently develops mutations.

New mutations have been emerging in the genome of SARS-CoV-2, and evolving of more virulent and treatment-resistant strains has the potential to increase transmissibility and mortality rates. 6 The molecular characterization of full-length SARS-CoV-2 sequences is necessary to understand the origin, transmission pathways and to identify the mutations that affect the transmissibility and pathogenicity of the virus. In addition, the analysis of genomic sequence data will provide valuable information for therapeutic and vaccine development studies.

Throughout the period of the COVID-19 pandemic, genetic variants of SARS-CoV-2 have emerged and spread around the world. Genetic differences between viruses have been compared to identify variants and their relation to each other to understand the transmission trends. The availability of virus genome sequences and online sequence sharing tools allowed for close monitoring of SARS-CoV-2 molecular epidemiology (Table 1) . Several studies have been conducted during the pandemic to reveal the genomic characterization and phylogenetic relationships of SARS-CoV-2 genomes circulating in Turkey. The first SARS-CoV-2 genome sequence shared from Turkey was made available via Global Initiative on Sharing All Influenza Data (GISAID) on March 25, 2020, and over 4000 sequences from Turkey had been released by May 31, 2021, in GISAID ( Figure 1 ). Molecular characterization and phylogenetic analysis of the first SARS-CoV-2 full-length genomes isolated in Turkey revealed virus introductions from Europe into Turkey. 7 SARS-CoV-2 genomes isolated and sequenced in Turkey revealed that the virus was introduced to the country earlier than the first reported case. 8 Since the start of the pandemic, the virus has undergone multiple nucleotide substitutions, including silent and missense mutations, according to the genomic characterization investigations of SARS-CoV-2 genomes in Turkey. 9, 10 According to nomenclature systems, SARS-CoV-2 genomes isolated in Turkey are found in most lineages, and data on virus genome diversity in Turkey reflects multiple introductions from various sources and subsequent local adaptation of the virus. 8, 10 The first positive case in our virology laboratory was detected on March 23, 2020. Since the beginning of the pandemic, over 80 000 samples have been tested and more than 12 000 of the samples were found positive in our laboratory. In this study, the mutation profile of fulllength genome sequence data obtained from specimens tested positive for SARS-CoV-2 in our laboratory is analyzed. We present an overview of the mutation pattern and the phylogenetic analysis of the genomes. We determine the clade distribution according to the three nomenclature systems (Pango lineage, Nextstrain, and GISAID) to understand the phylogenetic context and genomic diversity of the isolates in relation to global data.

The study included 20 male and 25 female patients, a total of 45 samples with average ages of 38.1 (between ages of 1 and 83), tested positive for SARS-CoV-2 with C t values less than 20, which were T A B L E 1 Current variants of concern (VOC) which are monitored and characterized are listed since the viral nucleic acid extraction buffer in vNAT transfer tubes causes RNA degradation and nucleic acid loss and also a high viral load is required for a good performance in the next-generation sequencing (NGS). We only had vNAT transfer tubes with viral nucleic acid extraction buffer causing nucleic acid loss during the long-term storage of the samples. Therefore, we selected recent specimens handled in our laboratory that were assumed to contain high viral loads. A high viral load containing a good quality nucleic acid is required to obtain significant results in the NGS. We thought that we would have a greater opportunity of obtaining high-quality PCR products and get better NGS results when high viral load containing samples are used. Another reason for selecting the samples with high viral loads is that there is some evidence of the association between high viral loads and increased infectivity 13 and disease severity. 14 

Purified viral RNA was converted into cDNA by reverse transcription reaction. The reaction was performed using 5 µl of viral nucleic acid extract. The extraction material, 6 µl of nuclease-free water and the 3 µl of RT primer mix were combined. The reaction mixture was incubated for 5 min at 65°C on a thermal cycler. Following the primer annealing, 1 µl of RT enzyme and 5 µl RT reaction buffer were added into the reaction mixture and the final mixture was incubated for 10 min at 8°C then for 80 min at 42°C on a thermal cycler. Following the RT reaction, 2 µl of stop buffer was added to each tube. The RT-PCR materials were cleaned using the method of 2.2X bead-based purification.

The entire viral genome was amplified with a multiplexed target en- 

The third step was the digestion reaction of the amplified DNA fragments, which performs background cleaning by eliminating nonspecific PCR products. The digestion reaction mixture was performed in 20 µl volumes, consisting of 7 µl of nuclease-free water, 2 µl of reagent buffer, 1 µl of digestion reagent, and 10 µl of purified sample from the previous step. The final reaction mixtures were incubated for 10 min at 37°C on a thermal cycler. Following the incubation, 2 µl of stop buffer was added to each tube. The postdigestion reaction materials were cleaned using the method of 1.3X bead-based purification.

The index sequences were added to each amplified DNA fragment using the combination of i5 and i7 primers designed for the Illumina sequencing platforms. The indexing reaction mixture was performed in 40 µl, consisting of 18 µl of nuclease-free water, 8 µl of 5X PCR Mix, 10 µl of purified sample from the previous step, 2 µl of each unique indexed PCR primers referred to i5 and i7. A thermal cycler protocol was programmed for initial denaturation for 10 min at 95°C, followed by 10 cycles of denaturation for 15 s at 98°C, annealing/ extension for 75 s at 60°C. PCR amplicons were cleaned using the method of 1X bead-based purification.

The quantity of indexed libraries was measured in ng/µl unit on 

The sequencing run was created with Local Run Manager software installed on the iSeq. 100 instrument. Using the Generate FASTQ Analysis module with the custom library preparation kit options, the number of sequencing cycles was set to 151 bp and the paired-end sequencing option was determined. The pooled libraries were loaded onto iSeq 100 system using iSeq. 100 i1

Reagent v1 (Illumina).

The removal of adapter sequences from demultiplexed FASTQ files was performed with the Cutadapt v3.0 tool. 15 Further analysis of the trimmed raw sequencing reads was done using Genome Detective Virus Tool. Genome Detective Virus Tool is a webbased software that evaluates the read quality, removes lowquality reads, performs read mapping, assembles the reads, and generates consensus sequences for NGS data. 16 

Sequences with suspected underlying sequencing errors (10/45 sequences) according to Nextclade quality metrics were excluded from the analysis. In total, 35 SARS-CoV-2 genome sequences were analyzed. Mutations with a recurrence of more than 11 sequences are shown in Table 3 . 

Three nomenclature schemes are illustrated on the tree (Figure 2 ).

Clustering the sequences according to the GISAID scheme shows three major GISAID clades. Out of 35 sequences, 9 sequences in G-clade, 19 sequences in GR-clade, and 6 sequences in GH-clade were classified. These sequences were grouped into two main Nextstrain clades. The 20B clade is found to be the most prevalent (21 sequences). Table 5 .

Since the beginning of the pandemic, the SARS-CoV-2 genome has been rapidly evolving and there has been evidence that the occurring found that the co-occurrence of these mutations is high in sequences obtained from Turkey. 8, 28, 31 The D614G mutation gradually became dominant throughout the world during the pandemic. The D614G mutation is found to be associated with higher viral loads in patients. 32 The spike protein is responsible for the attachment and entrance of the virus to the host cell.

S protein mutations and their effects on virulence should be closely monitored and evaluated, as this protein is the main target in the current vaccine development studies. 33 3037C>T mutation in the nsp3 gene region has appeared in 34 of 35 analyzed sequences, which corresponds to 97.2% of all sequences and is almost always accompanied by D614G and P323L mutations. A similar scenario was observed in another study which was also carried out in Turkey. 9 In a recent study comparing mutation profiles according to disease severity, D614G and P323L mutations in SARS-CoV-2 are found to be correlated to severe COVID-19 cases. 34 One of the most globally common 5′-UTR mutations in the SARS-CoV-2 genome is the 241C>T and it was also present in all of our sequences. Studies in some viral genomes have reported that variations in UTRs may affect the activity of viral RNA folding and packaging. 35 Although 241C>T mutation has an uncertain significance, the results of a study indicated that the mutation causes a decrease in the replication rates which results in a reduction of the mortality rates. 36 The mutation 241C>T has been reported to be co- Based on the phylogenetic tree, the clustering of the se- 

SARS and other coronaviruses as causes of pneumonia

A new coronavirus associated with human respiratory disease in China

Alp Meşe E. COVID-19 outbreak control, example of ministry of health of Turkey

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey

Phylogenetic analysis of SARS-CoV-2 genomes in Turkey

Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey

A crosssectional overview of SARS-CoV-2 genome variations in Turkey

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Nextstrain: real-time tracking of pathogen evolution

SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Cutadapt removes adapter sequences from highthroughput sequencing reads

Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes

MALVIRUS: an integrated web application for viral variant calling

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118

Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program

CoV-GLUE: a web application for tracking SARS-CoV-2 genomic variation

PhyloSuite: an integrated and scalable desktop platform for streamlined molecular sequence data management and evolutionary phylogenetics studies

ModelFinder: fast model selection for accurate phylogenetic estimates

MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space

disease and diplomacy: GISAID's innovative contribution to global health

Molecular epidemiology surveillance of SARS-CoV-2: mutations and genetic diversity one year after emerging

Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest

Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations

Geographic and genomic distribution of SARS-CoV-2 mutations

Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR −/− mice

Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus

Mutations in SARS-CoV-2 Leading to antigenic variations in spike protein: a challenge in vaccine development

Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19

Tricks an IRES uses to enslave ribosomes

In-silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and HNRNP-1. bioRxiv

Genotyping coronavirus SARS-CoV-2: methods and implications

Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice

The mechanism of resistance to favipiravir in influenza

Genomewide identification and characterization of point mutations in the SARS-CoV-2 genome. Osong Public Health Res Perspect

RdRp mutations are associated with SARS-CoV-2 genome evolution

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Domains and functions of spike protein in SARS-Cov-2 in the context of vaccine design

The coronavirus nucleocapsid is a multifunctional protein

Overview of immune response during SARS-CoV-2 infection: lessons from the past

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70. bioRxiv

Neutralising antibodies in spike mediated SARS-CoV-2 adaptation. medRxiv

Large scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management

Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins

The authors declare that there is no conflict of interest.